SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for Clinical Trial NCT03702205

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

The Effect of Betaine Supplementation on Body Composition and Physical Capacity of Speed-strength Male Athletes

The study is aimed at assessing the influence of two betaine doses (2.5 g∙d-1 and 5 g∙d-1) supplemented for three weeks in a group of speed-strength trained athletes on anaerobic capacity in Wingate test, performance in CrossFit-like exercise test - Fight Gone Bad, alterations in body compositions and total body water.

NCT03702205 Supplementation Sport

2 Interventions

Name: Betaine supplementation

Description: Group taking oral betaine supplementation

Type: Dietary Supplement

Betaine supplementation Placebo treatment

Name: Placebo treatment

Description: Group taking oral supplementation with placebo (starch) in a similar capsule form.

Type: Dietary Supplement

Betaine supplementation Placebo treatment


Primary Outcomes

Description: Fat mass (kg) and fat free mass (kg) analysis

Measure: Changes in fat mass and fat free mass after betaine supplementation

Time: Baseline and after 3 weeks

Description: The Wingate cycling test (W)

Measure: Changes in anaerobic capacity after betaine supplementation

Time: Baseline and after 3 weeks

Description: The CrossFit-specific physical fitness test: Fight Gone Bad (reps.)

Measure: Changes in specific performance capacity after betaine supplementation

Time: Baseline and after 3 weeks

Secondary Outcomes

Description: Total body water content (%)

Measure: Changes in total body water after betaine supplementation

Time: Baseline and after 3 weeks

Description: Testosterone level (ng/L)

Measure: Changes in testosterone level (ng/L) after betaine supplementation

Time: Baseline and after 3 weeks

Description: Amino acid profile (μmol/L)

Measure: Changes in amino acid profile after betaine supplementation

Time: Baseline and after 3 weeks

Description: Blood betaine (µmol/L)

Measure: Changes in blood betaine

Time: Baseline and after 3 weeks

Description: Total, LDL and HDL cholesterol (mg/dL) and triacylglycerol (mg/dL)

Measure: Changes in total, LDL and HDL cholesterol and triacylglycerol after betaine supplementation

Time: Baseline and after 3 weeks

Description: MTHFR (rs1801133) polymorphism

Measure: Difference in response to betaine supplementation depending on MTHFR (rs1801133) polymorphism

Time: Baseline and after 3 weeks

Purpose: Treatment

Allocation: Randomized

Crossover Assignment


There is one SNP

SNPs


1 rs1801133

Difference in response to betaine supplementation depending on MTHFR (rs1801133) polymorphism.

MTHFR (rs1801133) polymorphism.



HPO Nodes